I asked myself this same question today. I think most of the PPS should include assumed FDA approval. What could happen between today and June 27th? The following were evident to me as I watched the ADCOM unfold:
1. Briefing docs: highly favorable towards ARNA, drafted by the FDA themselves 2. FDA presentation: favored ARNA. I got the notion the FDA wants to approve lorc, but just needs the ADCOM blessings/advice to take into consideration 3. FDA said very possible to do a post-approval CV study and hinted to the fact that VVUS was going to do the same (hinted VVUS approval IMO).
That being said, what doubt is there the FDA will not approve lorc? The PPS should have FDA approval baked in to the tune of about 80%.